June 1, 2011
INNOVA, through its Boston based company, ICG, is joining the 300 exhibitors participating in the TechConnect World Expo held this year in Boston, Massachusetts on 13-16 June at the Hynes Convention Center. In particular, one of the R&D projects presented by Innova deals with early diagnosys of breast, lung and prosthate cancer (NAMDIATREAM).
TechConnect World Expo aims at matching innovative solutions to real world technology challenges with, this year, a particular technology focus on Clean Technologies, Nanotechnologies and Biotechnologies.
This will be an opportunity to create strategic partnerships, meet with leading global business development and R&D professionals, discuss about IP licensing, venture capital, corporate financing and access to advanced research insight and best practices.
TechConnect World is expected to bring together over 5,000 business and technical professionals including leading researchers, buyers, entrepreneurs, corporate business developers, investors, service providers, commercialization/tech transfer officers, industry analysts and members of the media from 70 countries.
More information on the TechConnect World website.
